Chemclin Diagnostics Co., Ltd. (SHA:688468)

Chemclin Diagnostics Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	406.2	436.29	445.34	465.27	470.77	418.2
Revenue Growth (YoY)	-10.88%	-2.03%	-4.28%	-1.17%	12.57%	-8.02%
Cost of Revenue	115.27	113.12	110.56	121.11	119.84	117.25
Gross Profit	290.93	323.17	334.78	344.16	350.94	300.95
Selling, General & Admin	129.87	136.61	133.41	135.17	143.23	129.03
Research & Development	72.28	73.74	65.14	68.36	66.78	54.33
Other Operating Expenses	5.66	5.38	5.03	5.49	3.66	3.22
Operating Expenses	207.73	215.53	203.17	209.05	213.82	186.87
Operating Income	83.2	107.65	131.61	135.11	137.12	114.09
Interest Expense	-6.69	-5.24	-0.47	-0.52	-0.73	-0.01
Interest & Investment Income	17.13	19.79	22.04	25.03	18.29	13.86
Currency Exchange Gain (Loss)	0.07	0.07	0.08	0.4	-0.13	-0.29
Other Non Operating Income (Expenses)	2.35	-0.09	-0.15	-0.08	-0.42	-0.08
EBT Excluding Unusual Items	96.07	122.18	153.12	159.93	154.13	127.57
Gain (Loss) on Sale of Assets	-0.14	0.06	0.14	-0.62	-0.64	-0.34
Asset Writedown	-5.05	-3.67	-2.8	-1.46	-0.32	-
Other Unusual Items	19.35	19.35	15.66	19.51	9.02	8.21
Pretax Income	110.23	137.92	166.12	177.37	162.19	135.44
Income Tax Expense	7.01	10.84	18.75	24.74	19.43	18.42
Net Income	103.23	127.07	147.37	152.63	142.76	117.02
Net Income to Common	103.23	127.07	147.37	152.63	142.76	117.02
Net Income Growth	-31.61%	-13.77%	-3.44%	6.91%	21.99%	-16.77%
Shares Outstanding (Basic)	392	397	398	402	386	355
Shares Outstanding (Diluted)	392	397	398	402	386	355
Shares Change (YoY)	-1.38%	-0.30%	-0.83%	4.10%	8.80%	76.55%
EPS (Basic)	0.26	0.32	0.37	0.38	0.37	0.33
EPS (Diluted)	0.26	0.32	0.37	0.38	0.37	0.33
EPS Growth	-30.65%	-13.51%	-2.63%	2.70%	12.12%	-52.86%
Free Cash Flow	60.23	60.46	-128.32	119.28	116.31	68.65
Free Cash Flow Per Share	0.15	0.15	-0.32	0.30	0.30	0.19
Dividend Per Share	0.125	0.125	0.125	0.347	0.170	-
Dividend Growth	-	-	-63.98%	104.12%	-	-
Gross Margin	71.62%	74.07%	75.17%	73.97%	74.54%	71.96%
Operating Margin	20.48%	24.67%	29.55%	29.04%	29.13%	27.28%
Profit Margin	25.41%	29.13%	33.09%	32.80%	30.32%	27.98%
Free Cash Flow Margin	14.83%	13.86%	-28.81%	25.64%	24.71%	16.41%
EBITDA	131.48	153.7	168.77	175.19	179.97	156.35
EBITDA Margin	32.37%	35.23%	37.90%	37.65%	38.23%	37.39%
D&A For EBITDA	48.28	46.05	37.16	40.08	42.84	42.26
EBIT	83.2	107.65	131.61	135.11	137.12	114.09
EBIT Margin	20.48%	24.67%	29.55%	29.04%	29.13%	27.28%
Effective Tax Rate	6.36%	7.86%	11.29%	13.95%	11.98%	13.60%
Revenue as Reported	406.2	436.29	445.34	465.27	470.77	418.2
Advertising Expenses	-	4.06	6.63	4.1	6.76	5.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.